Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 7
2018 4
2019 2
2020 7
2021 8
2022 7
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
2021 update on clinical trials in β-thalassemia.
Musallam KM, Bou-Fakhredin R, Cappellini MD, Taher AT. Musallam KM, et al. Among authors: bou fakhredin r. Am J Hematol. 2021 Nov 1;96(11):1518-1531. doi: 10.1002/ajh.26316. Epub 2021 Aug 18. Am J Hematol. 2021. PMID: 34347889 Free article. Review.
Beta-thalassemia: is cure still a dream?
Hodroj MH, Akiki N, Bou-Fakhredin R, Taher AT. Hodroj MH, et al. Among authors: bou fakhredin r. Minerva Med. 2023 Dec;114(6):850-860. doi: 10.23736/S0026-4806.23.08501-4. Epub 2023 Aug 3. Minerva Med. 2023. PMID: 37534831 Review.
Emerging Therapies in β-Thalassemia.
Bou-Fakhredin R, Kuo KHM, Taher AT. Bou-Fakhredin R, et al. Hematol Oncol Clin North Am. 2023 Apr;37(2):449-462. doi: 10.1016/j.hoc.2022.12.010. Hematol Oncol Clin North Am. 2023. PMID: 36907614 Review.
Clinical Complications and Their Management.
Bou-Fakhredin R, Motta I, Cappellini MD, Taher AT. Bou-Fakhredin R, et al. Hematol Oncol Clin North Am. 2023 Apr;37(2):365-378. doi: 10.1016/j.hoc.2022.12.007. Hematol Oncol Clin North Am. 2023. PMID: 36907609 Review.
Hypercoagulability and Vascular Disease.
Taher AT, Cappellini MD, Bou-Fakhredin R, Coriu D, Musallam KM. Taher AT, et al. Among authors: bou fakhredin r. Hematol Oncol Clin North Am. 2018 Apr;32(2):237-245. doi: 10.1016/j.hoc.2017.11.001. Epub 2017 Dec 1. Hematol Oncol Clin North Am. 2018. PMID: 29458729 Review.
Recommendations for pregnancy in Fanconi anemia.
Matar CF, Bou-Fakhredin R, Russo R, Andolfo I, Iolascon A, Taher AT. Matar CF, et al. Among authors: bou fakhredin r. Expert Opin Biol Ther. 2021 Nov;21(11):1403-1409. doi: 10.1080/14712598.2021.1913119. Epub 2021 Apr 12. Expert Opin Biol Ther. 2021. PMID: 33798394 Review.
Thalassemia and malignancy: An emerging concern?
Hodroj MH, Bou-Fakhredin R, Nour-Eldine W, Noureldine HA, Noureldine MHA, Taher AT. Hodroj MH, et al. Among authors: bou fakhredin r. Blood Rev. 2019 Sep;37:100585. doi: 10.1016/j.blre.2019.06.002. Epub 2019 Jun 22. Blood Rev. 2019. PMID: 31253373 Review.
Deferasirox: Over a Decade of Experience in Thalassemia.
Moukalled NM, Bou-Fakhredin R, Taher AT. Moukalled NM, et al. Among authors: bou fakhredin r. Mediterr J Hematol Infect Dis. 2018 Nov 1;10(1):e2018066. doi: 10.4084/MJHID.2018.066. eCollection 2018. Mediterr J Hematol Infect Dis. 2018. PMID: 30416698 Free PMC article. Review.
40 results